2BBBullish & Bearish
Health Care

Amgen Inc. (AMGN) Stock Score & Signals

Amgen Inc. (AMGN) trades on NASDAQ. It operates in the Health Care sector, Drug Manufacturers - General industry. Its current 2BB score is 47 out of 100.

About Amgen Inc.

Amgen Inc. is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. The company is ranked 18th on the list of largest biomedical companies by revenue. The name "AMGen" is a portmanteau of the company's original name, Applied Molecular Genetics. The company's major products are Prolia and XGEVA to treat osteoporosis and bone diseases, Repatha to treat hyperlipidemia, Otezla to treat psoriasis and psoriatic arthritis, Enbrel to treat autoimmune diseases, Evenity to treat osteoporosis, Tepezza to treat Graves' ophthalmopathy, Blincyto to treat acute ly...

2BB score and signals

Amgen Inc.’s current 2BB score is 47 out of 100, built from the signal categories below.

SignalScoreReading
Activity50Moderate
Momentum53Stable
Financial strength73Strong
Quality97Very Strong
Risk30Low

Company facts

CEORobert A. Bradway
HeadquartersThousand Oaks, California, United States
Founded1980
Employees31.5K
P/E ratio26.46
52-week range$288.00 – $447.01

Recent earnings

Report dateEPS actualEPS estimateRevenue actualRevenue estimate
2027-02-01—5.9198—$10.46B
2026-11-03—5.902—$10.25B
2026-08-04—5.7281—$9.61B
2026-04-305.154.8522$8.62B$8.75B